We demonstrate that activation of EphB2 induces tau dephosphorylation at multiple AD-related sites with mechanisms involving the EphB2 kinase-coupled PI3K/Akt activation and GSK-3β inhibition. Here, MAPT is linked to Alzheimer disease.